Feb 27, 2026 07:30AM
Feb 27, 2026 07:30AM
Feb 24, 2026 05:20PM
Feb 17, 2026 07:46AM
Feb 17, 2026 07:45AM
Feb 12, 2026 07:45AM
Feb 2, 2026 07:45AM TuHURA Biosciences receives FDA orphan drug designation for melanoma treatment
Feb 2, 2026 07:45AM
Dec 15, 2025 07:51AM
Dec 15, 2025 07:50AM
Dec 11, 2025 07:30AM
Dec 11, 2025 07:30AM
Dec 9, 2025 09:50AM
Dec 9, 2025 09:49AM TuHURA Biosciences, Inc. Announces $15.6 Million Registered Direct Offering
Dec 8, 2025 07:50AM
Dec 8, 2025 07:50AM
Nov 14, 2025 07:00AM
Nov 3, 2025 09:02AM
Nov 3, 2025 09:01AM
Aug 20, 2025 08:00AM
Aug 14, 2025 04:15PM TuHURA Biosciences, Inc. Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
Jul 1, 2025 08:50AM
Jul 1, 2025 08:50AM
Jun 30, 2025 08:51AM
Jun 30, 2025 08:50AM
Jun 24, 2025 08:04AM
Jun 24, 2025 08:00AM
Jun 23, 2025 05:02PM TuHURA Biosciences (HURA) and Kineta (KANT) Receive Stockholders Approval of Proposed Merger and All Related Proposals
Jun 23, 2025 05:00PM
Jun 23, 2025 09:16AM
Jun 9, 2025 08:01AM
Jun 9, 2025 08:00AM
Jun 3, 2025 10:00AM
Jun 3, 2025 09:58AM
May 15, 2025 04:10PM TuHURA Biosciences, Inc. Reports First Quarter 2025 Financial Results and Provides a Corporate Update
May 13, 2025 08:00AM
May 5, 2025 08:06AM
May 5, 2025 08:00AM
Apr 28, 2025 08:04AM
Apr 28, 2025 08:00AM
Apr 8, 2025 08:00AM
Apr 7, 2025 08:25AM TuHURA Biosciences (HURA) Appoints Dr. Bertrand Le Bourdonnec as Executive Vice President, Head of Drug Discovery, Early Development, and Program Management
Apr 7, 2025 08:24AM
Apr 1, 2025 08:00AM
Mar 11, 2025 08:05AM
Mar 10, 2025 09:00AM
Feb 19, 2025 09:00AM
Dec 13, 2024 01:21PM
Dec 12, 2024 08:46AM TuHURA Biosciences (HURA) Enters into Definitive Merger Agreement to Acquire Kineta, Inc.
Dec 12, 2024 08:45AM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All